# Immunovant: Biopharma, New York, United States

> Immunovant: Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Source: https://millionrounds.com/startup/immunovant (Millionrounds; every figure on the page links to its filing or article)

United States · [Biopharma startup](https://millionrounds.com/companies)

# Immunovant

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Funding reported Last round: Post ipo equity

Biopharma New York, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 101 51 to 200 people
- **Funding reported:** $864M in dollars
- **Last round:** Post ipo equity Sept 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Immunovant has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Immunovant raised

Funding, as reported

Reported in all **$864M** in dollars

Rounds **4**

Last round **Post ipo equity**

Last round date **Sept 2023**

Investors listed **8**

SEC Form D **$450M sold, 1 filing, last Jan 2025**

## Founders and team

From Immunovant's own website: 6 on the team.

- **Becky Merlina** Senior Vice President, Global Head of Quality
- **Chedvi Levin-Sister** Vice President of Finance
- **Christine Blodgett** Senior Vice President of Human Resources
- **Imara Charles PhD** Vice President, Global Supply Chain
- **Michael Miller** Vice President, Information Technology and Facilities
- **Tiago Girão** Chief Financial Officer

## On a portfolio page

Investors who name them

- [Altium Capital](https://millionrounds.com/fund/altium-capital)

Each firm lists Immunovant on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biopharma in United States

Startups like it

- [**Altos Labs** San Francisco · founded 2021](https://millionrounds.com/startup/altos-labs)
- [**Vaxcyte** San Carlos · founded 2013](https://millionrounds.com/startup/vaxcyte)
- [**Madrigal Pharmaceuticals** Conshohocken · founded 2011](https://millionrounds.com/startup/madrigal-pharmaceuticals)
- [**Harmony Biosciences** Plymouth Meeting · founded 2017](https://millionrounds.com/startup/harmony-biosciences)
- [**Kura Oncology** La Jolla · founded 2014](https://millionrounds.com/startup/kura-oncology)
- [**Solugen** Houston · founded 2016](https://millionrounds.com/startup/solugen-2)
- [**Dianthus Therapeutics** Waltham · founded 2019](https://millionrounds.com/startup/dianthus-therapeutics)
- [**Day One Biopharmaceuticals** South San Francisco · founded 2018](https://millionrounds.com/startup/day-one-biopharmaceuticals)

## Is this your company?

Add your raise, your deck and your story, and put Immunovant in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)